Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2023-03-31 00:00:00 ET · period of report 2023-03-29 · accession 0001104659-23-040415 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-31 | 2023-03-29 | RYTM | Roberts William T. | CAO | M - OptEx | — | +2,500 | 8,784 | +40% | — |
| D | 2023-03-31 | 2023-03-29 | RYTM | Roberts William T. | CAO | S - Sale+OE | $17.50 | -912 | 7,872 | -10% | -$16.0K |
| D | 2023-03-31 | 2023-03-29 | RYTM | Roberts William T. | CAO | M - OptEx | $0.00 | -2,500 | 5,000 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-29 | M | A | 2,500 | — | 8,784 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Common | Common Stock | 2023-03-29 | S | D | 912 | $17.50 | 7,872 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-03-29 | M | D | 2,500 | $0.00 | 5,000 | D | — · — to — | 2,500 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest or have vested as to 50% of the shares on each of March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date. |